• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对 α-突触核蛋白的工程化单体结合蛋白能有效抑制淀粉样纤维的增殖。

An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils.

机构信息

Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.

出版信息

Elife. 2019 Aug 21;8:e46112. doi: 10.7554/eLife.46112.

DOI:10.7554/eLife.46112
PMID:31389332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6721797/
Abstract

Removing or preventing the formation of [Formula: see text]-synuclein aggregates is a plausible strategy against Parkinson's disease. To this end, we have engineered the [Formula: see text]-wrapin AS69 to bind monomeric [Formula: see text]-synuclein with high affinity. In cultured cells, AS69 reduced the self-interaction of [Formula: see text]-synuclein and formation of visible [Formula: see text]-synuclein aggregates. In flies, AS69 reduced [Formula: see text]-synuclein aggregates and the locomotor deficit resulting from [Formula: see text]-synuclein expression in neuronal cells. In biophysical experiments in vitro, AS69 highly sub-stoichiometrically inhibited both primary and autocatalytic secondary nucleation processes, even in the presence of a large excess of monomer. We present evidence that the AS69-[Formula: see text]-synuclein complex, rather than the free AS69, is the inhibitory species responsible for sub-stoichiometric inhibition of secondary nucleation. These results represent a new paradigm that high affinity monomer binders can lead to strongly sub-stoichiometric inhibition of nucleation processes.

摘要

去除或阻止[公式:见文本]-突触核蛋白聚集体的形成是对抗帕金森病的一种合理策略。为此,我们设计了[公式:见文本]-包裹的 AS69 以高亲和力结合单体[公式:见文本]-突触核蛋白。在培养的细胞中,AS69 减少了[公式:见文本]-突触核蛋白的自我相互作用和可见[公式:见文本]-突触核蛋白聚集体的形成。在果蝇中,AS69 减少了[公式:见文本]-突触核蛋白聚集体和神经元细胞中[公式:见文本]-突触核蛋白表达导致的运动缺陷。在体外的生物物理实验中,AS69 以亚化学计量的方式高度抑制了一级和自动催化的二级成核过程,即使在存在大量单体的情况下也是如此。我们提供的证据表明,AS69-[公式:见文本]-突触核蛋白复合物而不是游离的 AS69 是负责亚化学计量抑制二级成核的抑制性物质。这些结果代表了一个新的范例,即高亲和力单体结合物可以导致成核过程的强烈亚化学计量抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911d/6721797/e3be2dbc3ff7/elife-46112-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911d/6721797/9024946e79db/elife-46112-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911d/6721797/e3be2dbc3ff7/elife-46112-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911d/6721797/9024946e79db/elife-46112-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911d/6721797/e3be2dbc3ff7/elife-46112-fig2.jpg

相似文献

1
An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils.一种针对 α-突触核蛋白的工程化单体结合蛋白能有效抑制淀粉样纤维的增殖。
Elife. 2019 Aug 21;8:e46112. doi: 10.7554/eLife.46112.
2
Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression.基于α-突触核蛋白过表达的小鼠模型中评估β-Wrapin AS69 的效果。
Biomolecules. 2024 Jun 25;14(7):756. doi: 10.3390/biom14070756.
3
Impact of subunit linkages in an engineered homodimeric binding protein to α-synuclein.工程化同二聚体结合蛋白中各亚基连接对α-突触核蛋白的影响。
Protein Eng Des Sel. 2014 Dec;27(12):473-9. doi: 10.1093/protein/gzu047. Epub 2014 Oct 20.
4
A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons.一种靶向α-突触核蛋白单体N端的β-包裹蛋白可减少神经元中纤维诱导的聚集。
Front Neurosci. 2021 Jul 13;15:696440. doi: 10.3389/fnins.2021.696440. eCollection 2021.
5
α-Synuclein Dimers as Potent Inhibitors of Fibrillization.α-突触核蛋白二聚体作为纤维形成的有效抑制剂。
J Med Chem. 2019 Nov 27;62(22):10342-10351. doi: 10.1021/acs.jmedchem.9b01400. Epub 2019 Nov 4.
6
Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates.单体和纤维状的α-突触核蛋白对促进 Aβ42 聚集物增殖的催化循环有相反的影响。
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8005-8010. doi: 10.1073/pnas.1700239114. Epub 2017 Jul 11.
7
β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.β-突触核蛋白通过与表面竞争性结合来抑制α-突触核蛋白聚集的起始和扩增步骤。
Sci Rep. 2016 Nov 3;6:36010. doi: 10.1038/srep36010.
8
α-Synuclein aggregation at low concentrations.α-突触核蛋白在低浓度下的聚集。
Biochim Biophys Acta Proteins Proteom. 2019 Jul-Aug;1867(7-8):701-709. doi: 10.1016/j.bbapap.2019.05.003. Epub 2019 May 13.
9
Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature α-synuclein fibrils.眼晶状体晶体蛋白抑制成熟α-突触核蛋白原纤维的自催化淀粉样纤维扩增特性。
PLoS One. 2020 Jun 29;15(6):e0235198. doi: 10.1371/journal.pone.0235198. eCollection 2020.
10
Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates.基于结构的α-突触核蛋白聚集物自催化增殖小分子抑制剂的发现。
Mol Pharm. 2023 Jan 2;20(1):183-193. doi: 10.1021/acs.molpharmaceut.2c00548. Epub 2022 Nov 14.

引用本文的文献

1
Using a stable protein scaffold to display peptides that bind to alpha-synuclein fibrils.利用稳定的蛋白质支架展示与α-突触核蛋白原纤维结合的肽段。
Protein Sci. 2025 Jun;34(6):e70150. doi: 10.1002/pro.70150.
2
Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression.基于α-突触核蛋白过表达的小鼠模型中评估β-Wrapin AS69 的效果。
Biomolecules. 2024 Jun 25;14(7):756. doi: 10.3390/biom14070756.
3
A Potent Sybody Selectively Inhibits α-Synuclein Amyloid Formation by Binding to the P1 Region.

本文引用的文献

1
Monitoring α-synuclein multimerization in vivo.在体监测α-突触核蛋白寡聚化。
FASEB J. 2019 Feb;33(2):2116-2131. doi: 10.1096/fj.201800148RRR. Epub 2018 Sep 25.
2
Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.通过高通量筛选鉴定出有效的α-突触核蛋白聚集抑制剂,主要针对单体状态。
Cell Chem Biol. 2018 Nov 15;25(11):1389-1402.e9. doi: 10.1016/j.chembiol.2018.08.005. Epub 2018 Sep 6.
3
A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
一种强效的 Sybody 通过结合 P1 区域选择性地抑制α-突触核蛋白淀粉样形成。
J Med Chem. 2024 Jun 27;67(12):9857-9868. doi: 10.1021/acs.jmedchem.3c02408. Epub 2024 Jun 6.
4
Protein mimetic 2D FAST rescues alpha synuclein aggregation mediated early and post disease Parkinson's phenotypes.蛋白模拟 2D FAST 挽救了与帕金森病早发和发病后相关的α-突触核蛋白聚集。
Nat Commun. 2024 Apr 30;15(1):3658. doi: 10.1038/s41467-024-47980-4.
5
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.错误折叠的蛋白质寡聚物:形成机制、细胞毒性作用以及针对蛋白质错误折叠疾病的药理学方法。
Mol Neurodegener. 2024 Feb 20;19(1):20. doi: 10.1186/s13024-023-00651-2.
6
The 75-99 C-Terminal Peptide of URG7 Protein Promotes α-Synuclein Disaggregation.URG7 蛋白的 75-99 C 端肽促进 α-突触核蛋白解聚。
Int J Mol Sci. 2024 Jan 17;25(2):1135. doi: 10.3390/ijms25021135.
7
Nucleation of α-Synuclein Amyloid Fibrils Induced by Cross-Interaction with β-Hairpin Peptides Derived from Immunoglobulin Light Chains.免疫球蛋白轻链衍生的 β 发夹肽通过交叉相互作用诱导 α-突触核蛋白淀粉样纤维的成核。
Int J Mol Sci. 2023 Nov 9;24(22):16132. doi: 10.3390/ijms242216132.
8
Mechanisms and pathology of protein misfolding and aggregation.蛋白质错误折叠和聚集的机制和病理学。
Nat Rev Mol Cell Biol. 2023 Dec;24(12):912-933. doi: 10.1038/s41580-023-00647-2. Epub 2023 Sep 8.
9
Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders.溶血磷脂:神经退行性疾病的潜在候选药物
Biomedicines. 2022 Dec 3;10(12):3126. doi: 10.3390/biomedicines10123126.
10
Pyrogallol, Corilagin and Chebulagic acid target the "fuzzy coat" of alpha-synuclein to inhibit the fibrillization of the protein.连苯三酚、柯里拉京和诃子鞣酸靶向α-突触核蛋白的“模糊外套”以抑制该蛋白的纤维化。
RSC Adv. 2022 Dec 14;12(55):35770-35777. doi: 10.1039/d2ra04358k. eCollection 2022 Dec 12.
一种 d-对映异构体肽干扰淀粉样β寡聚物和朊病毒蛋白的异源聚合。
J Biol Chem. 2018 Oct 12;293(41):15748-15764. doi: 10.1074/jbc.RA118.003116. Epub 2018 Aug 21.
4
Secondary nucleation of monomers on fibril surface dominates α-synuclein aggregation and provides autocatalytic amyloid amplification.单体在原纤维表面的二次成核主导了α-突触核蛋白的聚集,并提供了自动催化的淀粉样扩增。
Q Rev Biophys. 2017 Jan;50:e6. doi: 10.1017/S0033583516000172.
5
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.帕金森病的过去、现在和未来:震颤麻痹 200 周年专论。
Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115.
6
Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species.针对单体 α-突触核蛋白的纳米抗体可抑制纤维形成并破坏有毒的寡聚体。
BMC Biol. 2017 Jul 3;15(1):57. doi: 10.1186/s12915-017-0390-6.
7
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.一种天然产物可抑制α-突触核蛋白聚集的起始并抑制其毒性。
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E1009-E1017. doi: 10.1073/pnas.1610586114. Epub 2017 Jan 17.
8
β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.β-突触核蛋白通过与表面竞争性结合来抑制α-突触核蛋白聚集的起始和扩增步骤。
Sci Rep. 2016 Nov 3;6:36010. doi: 10.1038/srep36010.
9
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.一种靶向α-突触核蛋白的新型化合物可改善帕金森病模型中的缺陷。
Brain. 2016 Dec;139(Pt 12):3217-3236. doi: 10.1093/brain/aww238. Epub 2016 Sep 27.
10
Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.与家族性帕金森病相关的突变会改变α-突触核蛋白聚集的起始和扩增步骤。
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10328-33. doi: 10.1073/pnas.1604645113. Epub 2016 Aug 29.